APPLICATION
ANDA211504
TYPE
ANDA
ORIGINAL APPROVAL
2018-10-26
LATEST ACTION
2020-08-04
ROUTE
INTRAMUSCULAR, INTRAVENOUS, IM-IV
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
METHOCARBAMOLPrescription
METHOCARBAMOL 1GM/10ML (100MG/ML) · SOLUTION · IM-IV
Approval history
2020-08-04Labeling · Supplement 1 · standardAP
2018-10-26UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.